Bone Resorption, Osteoclastogenesis and Adalimumab

NCT02035800 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

RheumatoId Arthritis

Interventions

DRUG: Adalimumab

Sponsor

Université de Sherbrooke

Collaborators

[object Object]